DK1001942T3 - Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser - Google Patents

Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser

Info

Publication number
DK1001942T3
DK1001942T3 DK98939677T DK98939677T DK1001942T3 DK 1001942 T3 DK1001942 T3 DK 1001942T3 DK 98939677 T DK98939677 T DK 98939677T DK 98939677 T DK98939677 T DK 98939677T DK 1001942 T3 DK1001942 T3 DK 1001942T3
Authority
DK
Denmark
Prior art keywords
polyhydroxybutylpyrazines
compounds
well
preparation
drugs containing
Prior art date
Application number
DK98939677T
Other languages
Danish (da)
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1001942T3 publication Critical patent/DK1001942T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98939677T 1997-07-17 1998-07-15 Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser DK1001942T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
PCT/FR1998/001543 WO1999003841A1 (fr) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
DK1001942T3 true DK1001942T3 (da) 2003-10-20

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939677T DK1001942T3 (da) 1997-07-17 1998-07-15 Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser

Country Status (25)

Country Link
US (1) US6288066B1 (cs)
EP (1) EP1001942B1 (cs)
JP (1) JP4443033B2 (cs)
KR (1) KR20010021871A (cs)
CN (1) CN1264368A (cs)
AT (1) ATE243683T1 (cs)
AU (1) AU745905B2 (cs)
BR (1) BR9810595A (cs)
CA (1) CA2296725C (cs)
CZ (1) CZ290896B6 (cs)
DE (1) DE69815854T2 (cs)
DK (1) DK1001942T3 (cs)
ES (1) ES2196595T3 (cs)
FR (1) FR2766183B1 (cs)
HU (1) HUP0004661A3 (cs)
IL (1) IL134039A0 (cs)
MX (1) MXPA00000437A (cs)
NO (1) NO20000199L (cs)
NZ (1) NZ502279A (cs)
PL (1) PL338147A1 (cs)
PT (1) PT1001942E (cs)
RU (1) RU2186773C2 (cs)
SK (1) SK462000A3 (cs)
WO (1) WO1999003841A1 (cs)
ZA (1) ZA986336B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
EP2121611B1 (en) * 2007-03-19 2015-04-15 DSM IP Assets B.V. UV-filter compounds based on alpha,beta-dihydroxyketones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600052A1 (de) * 1986-01-03 1987-07-09 Merck Patent Gmbh Heterocyclische verbindungen
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
AU745905B2 (en) 2002-04-11
PT1001942E (pt) 2003-11-28
EP1001942B1 (fr) 2003-06-25
RU2186773C2 (ru) 2002-08-10
CA2296725A1 (fr) 1999-01-28
CN1264368A (zh) 2000-08-23
WO1999003841A1 (fr) 1999-01-28
JP2001510185A (ja) 2001-07-31
DE69815854T2 (de) 2004-05-13
PL338147A1 (en) 2000-09-25
NO20000199D0 (no) 2000-01-14
FR2766183A1 (fr) 1999-01-22
KR20010021871A (ko) 2001-03-15
ZA986336B (en) 1999-01-27
DE69815854D1 (de) 2003-07-31
EP1001942A1 (fr) 2000-05-24
NZ502279A (en) 2002-04-26
NO20000199L (no) 2000-01-14
ES2196595T3 (es) 2003-12-16
BR9810595A (pt) 2000-09-12
ATE243683T1 (de) 2003-07-15
FR2766183B1 (fr) 1999-08-27
HUP0004661A3 (en) 2001-12-28
CA2296725C (fr) 2008-11-18
IL134039A0 (en) 2001-04-30
CZ2000121A3 (cs) 2000-05-17
HUP0004661A2 (hu) 2001-11-28
US6288066B1 (en) 2001-09-11
MXPA00000437A (es) 2002-04-17
CZ290896B6 (cs) 2002-11-13
SK462000A3 (en) 2000-06-12
AU8810398A (en) 1999-02-10
JP4443033B2 (ja) 2010-03-31

Similar Documents

Publication Publication Date Title
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
SE9704546D0 (sv) Novel compounds
NO973923L (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
DK310383A (da) 14-fluormorphinaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
NO163177C (no) Fremgangsmaate til fremstilling av varmefaste, formede artikler.
DK398583D0 (da) Spergualin-beslaegtede forbindelser, fremgangsmader til fremstilling deraf samt deres anvendelse som laegemidler
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
NO974563D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO984476D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO20000423D0 (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
FI901876A0 (fi) Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar.
NO984475D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
DK11089D0 (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
NO983577D0 (no) Sulfonamidsubstituerte forbindelser, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO873628L (no) 2,3-dihydro-1h-fenalen-2-amino-forbindelser som antipsykotiske legemidler.
DK222888A (da) Anellerede heteroalkylenquinolinaminer, isomere og salte deraf, deres fremstilling og anvendelse som laegemidler smat mellemprodukter til fremstillingen
DK260884D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK401883A (da) Kemiske forbindelser, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmidler med forlaenget virketid
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene